MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Signal intensity of cerebral gyri in corticobasal degeneration on phase difference enhanced MR images: Comparison with progressive supranuclear palsy and Parkinson’s disease

M. Miyata, S. Kakeda, T. Yoneda, S. Ide, K. Watanabe, J. Moriya, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

Meeting: 2017 International Congress

Abstract Number: 1521

Keywords: Corticobasal degeneration (CBD), Magnetic resonance imaging(MRI), Parkinsonism

Session Information

Date: Thursday, June 8, 2017

Session Title: Parkinson's Disease: Neuroimaging And Neurophysiology

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: We evaluated the signal intensity of the cerebral gyri (CG) on phase difference enhanced imaging (PADRE) for the patients with corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), and Parkinson’s disease (PD) to determine whether it is possible to discriminate among them on an individual basis.

Background: Typical MR findings in CBD are reliably found only in late disease. Therefore, from a neuroradiological point of view, differentiation between CBD from PD has traditionally proved challenging. PADRE is designed to select the phase difference between the object and surrounding tissue, and can enhance them selectively.1 Contrast on PADRE images can reflect not only iron content but also myelin density.2

Methods: All studies were performed on a 3T MR imaging system. Axial PADRE images was obtained with a 3D multi-echo spoiled gradient echo sequence. First, two reviewers evaluated the difference between the CG appearance of the healthy subjects and abnormal CG appearance of CBD patients on PADRE in a non-blinded manner. Then, based on the CG abnormalities, two other reviewers reviewed PADRE images from 9 CBD patients, 9 PSP and 20 PD in a blinded manner. In addition, for the conventional MRI, two reviewers independently reviewed typical findings (disappearance of subcortical WM hypointensity and low signal intensity layer in superficial GM) of CBD which have been reported previously.

Results: Regarding CBD-specific findings on PADRE, the radiologists found hypointense layer in the superficial gray matter and disappearance of hypointense subcortical white matter (Figure). The frequency of this sign in the blinded manner was 100% (9/9) in CBD patients and 45% (5/11) in PSP, whereas 5% (1/20) in PD. The typical findings in CBD on conventional MRI were observed in only 44% (4/9) of CBD patients.

Conclusions: Our study on PADRE images presented novel findings in the gyrus of CBD patients, which might be useful to discriminate CBD from PD on an individual basis.

References: 1.           Haacke EM, Xu Y, Cheng YCN, Reichenbach JR. Susceptibility weighted imaging (SWI). Magnetic resonance in medicine 2004;52(3):612-618.

2.           Kakeda S, Yoneda T, Ide S, Watanabe K, Hiai Y, Korogi Y. Signal intensity of superficial white matter on phase difference enhanced imaging as a landmark of the perirolandic cortex. Acta Radiologica 2015:0284185115585162.

To cite this abstract in AMA style:

M. Miyata, S. Kakeda, T. Yoneda, S. Ide, K. Watanabe, J. Moriya, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi. Signal intensity of cerebral gyri in corticobasal degeneration on phase difference enhanced MR images: Comparison with progressive supranuclear palsy and Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/signal-intensity-of-cerebral-gyri-in-corticobasal-degeneration-on-phase-difference-enhanced-mr-images-comparison-with-progressive-supranuclear-palsy-and-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/signal-intensity-of-cerebral-gyri-in-corticobasal-degeneration-on-phase-difference-enhanced-mr-images-comparison-with-progressive-supranuclear-palsy-and-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley